Design and synthesis of benzo[ b ]thiophene‐based hybrids as novel antitubercular agents against MDR/XDR Mycobacterium tuberculosis
Archiv der Pharmazie · 2024
DOI: 10.1002/ardp.202300529 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Tarfah Al-Warhi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Isatin, Tuberculosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Princess Nourah bint Abdulrahman University.
Abstract (Originalsprache)
In an effort to support the global fight against tuberculosis (TB), which is widely recognized as the most lethal infectious disease worldwide, we present the design and synthesis of new benzo[ b ]thiophene‐based hybrids as promising candidates for the management of multidrug‐resistant (MDR)/extensively drug‐resistant (XDR) Mycobacterium tuberculosis . The isatin motif was incorporated into the target hybrids as it represents a privileged scaffold in antitubercular drug discovery. Since lipophilicity plays a pivotal role in the anti‐TB agents' activity, the lipophilicity of the target hybrids was manipulated via the development of two series of N ‐1 methyl and N ‐1 benzyl substituted isatins ( 6a–h and 9a–h , respectively). Screening of the target hybrids was first performed against drug‐sensitive M. tuberculosis (ATCC 25177). The structure–activity relationship outputs highlighted that incorporation of 3‐unsubstituted benzo[ b ]thiophene and 5‐methoxy isatin moieties was favorable for the antimycobacterial activity. Thereafter, the most potent molecules ( 6b–h , 9c–e , and 9h ) were evaluated against the resistant strains MDR‐TB (ATCC 35822) as well as against XDR‐TB (RCMB 2674) where they displayed promising activity. To evaluate the safety of the target hybrids, an sulforhodamine B assay was conducted to determine their possible cytotoxic effects on VERO cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
- Scientific Research and Innovation Support Unit, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt.
- Department of Chemistry, University of Cambridge, Cambridge, UK.
- The Regional Center for Mycology and Biotechnology, Al-Azhar University, Cairo, Egypt.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt.
Förderung
- Princess Nourah bint Abdulrahman University
Zitieren
APA
Al-Warhi, T., Rashad, N. M., Almahli, H., Abdel-Aziz, M. M., Elsayed, Z. M., Shahin, M. I., & Eldehna, W. M. (2024). Design and synthesis of benzo[ b ]thiophene‐based hybrids as novel antitubercular agents against MDR/XDR Mycobacterium tuberculosis. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202300529
Vancouver
Al-Warhi T, Rashad NM, Almahli H, Abdel-Aziz MM, Elsayed ZM, Shahin MI, et al. Design and synthesis of benzo[ b ]thiophene‐based hybrids as novel antitubercular agents against MDR/XDR Mycobacterium tuberculosis. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202300529
BibTeX
@article{AlWarhi2024,
author = {Al-Warhi, Tarfah and Rashad, Nermeen M and Almahli, Hadia and Abdel-Aziz, Marwa M and Elsayed, Zainab M and Shahin, Mai I and Eldehna, Wagdy M},
title = {Design and synthesis of benzo[ b ]thiophene‐based hybrids as novel antitubercular agents against MDR/XDR Mycobacterium tuberculosis},
journal = {Archiv der Pharmazie},
year = {2024},
doi = {10.1002/ardp.202300529}
}
EUVIMED